FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vinod Vathipadiekal

Research Profile

Disorders

Physiology

Anatomy

Tumor Cell Line

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Mouse

Devices

Oligonucleotide Array Sequence Analysis

Co-author Network

Publications

TOP 3
Taymaa May; Michael Birrer; Christopher P Crum; Barry Rosen; Melina Shoni; Alicia Tone; Vinod Vathipadiekal; Wa Xian; K Joan Murphy
Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.
John Farley; Michael Birrer; William E Brady; Robert Coleman; Heather A Lankes; Robert Mannel; Mark A Morgan; David Mutch; William H Rodgers; Vinod Vathipadiekal; S Diane Yamada; David M Gershenson
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
Hua Li; Tianyu Li; Margarita Sánchez-Beato; Vinod Vathipadiekal; Hong Wu; Michael J Birrer; Qi Cai; Zachary C Dobbin; Xiang Hua; Charles N Landen; Rugang Zhang
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vinod Vathipadiekal (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Taymaa May; Michael Birrer; Christopher P Crum; Barry Rosen; Melina Shoni; Alicia Tone; Vinod Vathipadiekal; Wa Xian; K Joan Murphy
Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.
Gynecologic oncology 2013;128(3):488-92.
2013: John Farley; Michael Birrer; William E Brady; Robert Coleman; Heather A Lankes; Robert Mannel; Mark A Morgan; David Mutch; William H Rodgers; Vinod Vathipadiekal; S Diane Yamada; David M Gershenson
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
The lancet oncology 2013;14(2):134-40.
2012: Hua Li; Tianyu Li; Margarita Sánchez-Beato; Vinod Vathipadiekal; Hong Wu; Michael J Birrer; Qi Cai; Zachary C Dobbin; Xiang Hua; Charles N Landen; Rugang Zhang
SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.
Molecular cancer research : MCR 2012;10(11):1462-72.
2012: Anamika Verma; Mitchell White; Micheal Ieong; Jens C Jensenius; Julvet Mbianda; Li Qi; Kazue Takahashi; Jeffery K Taubenberger; Steffen Thiel; Shweta Tripathi; Vinod Vathipadiekal; Kevan L Hartshorn
Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(5):2478-87.
2012: Hua Li; Marie E Maradeo; Michael Slifker; Peter J Tummino; Vinod Vathipadiekal; Michael J Birrer; Benjamin G Bitler; Paul Cairns; Caretha L Creasy; Rugang Zhang
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approaches.
Cancer prevention research (Philadelphia, Pa.) 2012;5(3):484-91.
2012: Geetika Sethi; Vinod Vathipadiekal; Hong Zhang; Yan Zhou; Michael J Birrer; Margret B Einarson; Sumedha Gunewardena; Harsh B Pathak; Andrew K Godwin
An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
PloS one 2012;7(10):e47086.
2012: Vinod Vathipadiekal; Peter V Hauschka; Samuel C Mok; Laurent Ozbun; Deepa Saxena; Michael J Birrer
Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
PloS one 2012;7(1):e29079.
2011: Christopher K McCann; Gayatry Mohapatra; Jennifer L Proctor; Hana Sheikh; Vinod Vathipadiekal; Lawrence R Zukerberg; Michael J Birrer; Darrell R Borger; Michael D Curley; Igor Deyneko; Jeanne A Ferguson; Rosemary Foster; Anne M Friel; Whitfield B Growdon; Kashmira Kulkarni-Datar; John R Macdougall; Bo R Rueda
Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
PloS one 2011;6(11):e28077.
2010: Vinod Vathipadiekal; Perunthottathu K Umasankar; Milind S Patole; Mala Rao
Molecular cloning, over expression, and activity studies of a peptidic HIV-1 protease inhibitor: designed synthetic gene to functional recombinant peptide.
Peptides 2010;31(1):16-21.
2009: Samuel C Mok; Tomas Bonome; Vinod Vathipadiekal; Aaron Bell; Michael E Johnson; Kwong-Kwok Wong; Dong-Choon Park; Ke Hao; Daniel K P Yip; Howard Donninger; Laurent Ozbun; Goli Samimi; John Brady; Mike Randonovich; Cynthia A Pise-Masison; J Carl Barrett; Wing H Wong; William R Welch; Ross S Berkowitz; Michael J Birrer
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.
Cancer cell 2009;16(6):521-32.
2007: Vinod Vathipadiekal; Anamika Verma; Mala Rao
Glycine-assisted enhancement of 1,4-beta-d-xylan xylanohydrolase activity at alkaline pH with a pH optimum shift.
Biological chemistry 2007;388(1):61-5.
2004: Vinod Vathipadiekal; Mala Rao
Inhibition of 1,4-beta-D-xylan xylanohydrolase by the specific aspartic protease inhibitor pepstatin: probing the two-step inhibition mechanism.
The Journal of biological chemistry 2004;279(45):47024-33.
2002: Chandravanu Dash; Vinod Vathipadiekal; Sudeep George; Mala Rao
Slow-tight binding inhibition of xylanase by an aspartic protease inhibitor: kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor.
The Journal of biological chemistry 2002;277(20):17978-86.